Ora Keren

775 total citations
32 papers, 585 citations indexed

About

Ora Keren is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Ora Keren has authored 32 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cellular and Molecular Neuroscience, 17 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Ora Keren's work include Receptor Mechanisms and Signaling (16 papers), Neuroscience and Neuropharmacology Research (15 papers) and Cannabis and Cannabinoid Research (10 papers). Ora Keren is often cited by papers focused on Receptor Mechanisms and Signaling (16 papers), Neuroscience and Neuropharmacology Research (15 papers) and Cannabis and Cannabinoid Research (10 papers). Ora Keren collaborates with scholars based in Israel, United States and Russia. Ora Keren's co-authors include Yosef Sarne, Mikhal Gafni, M. Gafni, Amos D. Korczyn, Abraham Hefetz, Moshe Garty, Alla Guekht, Abraham Weizman, Rachel Maayan and Edward Ram and has published in prestigious journals such as Brain Research, British Journal of Pharmacology and Cellular and Molecular Life Sciences.

In The Last Decade

Ora Keren

32 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ora Keren Israel	16	387	237	219	102	96	32	585
Mikhal Gafni Israel	16	376 1.0×	352 1.5×	164 0.7×	95 0.9×	74 0.8×	19	560
Brian M. Kelley United States	14	344 0.9×	77 0.3×	227 1.0×	53 0.5×	88 0.9×	22	631
Trinidad Saez Argentina	11	320 0.8×	311 1.3×	131 0.6×	90 0.9×	70 0.7×	14	590
Eva Romero Spain	8	199 0.5×	200 0.8×	82 0.4×	64 0.6×	51 0.5×	12	573
Warren Logge Australia	13	201 0.5×	175 0.7×	92 0.4×	93 0.9×	134 1.4×	33	597
Maria Gomis‐González Spain	11	230 0.6×	279 1.2×	119 0.5×	180 1.8×	60 0.6×	17	565
Tom�s A. Reader Canada	12	280 0.7×	58 0.2×	128 0.6×	49 0.5×	59 0.6×	17	502
C. Ascioti Italy	8	226 0.6×	54 0.2×	136 0.6×	115 1.1×	49 0.5×	13	513
Kelly J. Powell Canada	11	487 1.3×	79 0.3×	256 1.2×	52 0.5×	405 4.2×	17	770
Wenhua Han Japan	12	334 0.9×	57 0.2×	340 1.6×	58 0.6×	231 2.4×	16	648

Countries citing papers authored by Ora Keren

Since Specialization

Citations

This map shows the geographic impact of Ora Keren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ora Keren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ora Keren more than expected).

Fields of papers citing papers by Ora Keren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ora Keren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ora Keren. The network helps show where Ora Keren may publish in the future.

Co-authorship network of co-authors of Ora Keren

This figure shows the co-authorship network connecting the top 25 collaborators of Ora Keren. A scholar is included among the top collaborators of Ora Keren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ora Keren. Ora Keren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keren, Ora, et al.. (2013). A single pentylenetetrazole-induced clonic-tonic seizure episode is accompanied by a slowly developing cognitive decline in rats. Epilepsy & Behavior. 26(2). 196–202. 27 indexed citations

Gafni, Mikhal, et al.. (2012). Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling. Experimental Brain Research. 221(4). 437–448. 37 indexed citations

Gafni, Mikhal, et al.. (2011). Membrane-delimited proteolytic regulation of opioid receptors. Brain Research. 1386. 25–34. 3 indexed citations

Gafni, Mikhal, et al.. (2011). Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage. Behavioural Brain Research. 220(1). 194–201. 27 indexed citations

Keren, Ora, et al.. (2008). Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell. Brain Research. 1189. 23–32. 26 indexed citations

Keren, Ora, et al.. (2007). Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): Behavioral, pharmacological and biochemical studies in mice. Pharmacology Biochemistry and Behavior. 88(3). 230–237. 22 indexed citations

Keren, Ora, et al.. (2006). A single low dose of tetrahydrocannabinol induces long-term cognitive deficits. Neuroscience Letters. 411(2). 108–111. 21 indexed citations

Maayan, Rachel, et al.. (2006). The protective effect of frontal cortex dehydroepiandrosterone in anxiety and depressive models in mice. Pharmacology Biochemistry and Behavior. 85(2). 415–421. 30 indexed citations

Sarne, Yosef & Ora Keren. (2004). Are cannabinoid drugs neurotoxic or neuroprotective?. Medical Hypotheses. 63(2). 187–192. 28 indexed citations

10.

Keren, Ora & Yosef Sarne. (2003). Multiple mechanisms of CB1 cannabinoid receptors regulation. Brain Research. 980(2). 197–205. 35 indexed citations

11.

Keren, Ora, et al.. (2001). Divers pathways mediate δ-opioid receptor down regulation within the same cell. Molecular Brain Research. 96(1-2). 142–150. 18 indexed citations

12.

Keren, Ora, M. Gafni, & Yosef Sarne. (1999). Potentiation of transmitter release from NMB human neuroblastoma cells by kappa-opioids is mediated by N-type voltage-dependent calcium channels. Brain Research. 843(1-2). 193–198. 9 indexed citations

13.

Keren, Ora, M. Gafni, & Yosef Sarne. (1997). Opioids potentiate transmitter release from SK-N-SH human neuroblastoma cells by modulating N-type calcium channels. Brain Research. 764(1-2). 277–282. 17 indexed citations

14.

Sarne, Yosef, et al.. (1996). Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: Overview and original results. Neurochemical Research. 21(11). 1353–1361. 46 indexed citations

15.

Keren, Ora, Moshe Garty, & Yosef Sarne. (1994). Dual regulation by opioids of3H-norepinephrine release in the human neuroblastoma cell-line SK-N-SH. Brain Research. 646(2). 319–323. 17 indexed citations

16.

Gafni, M., et al.. (1993). Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.. Molecular Pharmacology. 44(2). 461–467. 41 indexed citations

17.

Heller, Lior, Ora Keren, L Mendelson, & Gary Davidoff. (1990). Transverse myelitis associated with mycoplasma pneumoniae: case report. Spinal Cord. 28(8). 522–525. 12 indexed citations

18.

Askenasy, J. J. M., et al.. (1990). Juvenile Parkinson's disease and its response to L-dopa therapy. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 2(1). 23–30. 3 indexed citations

19.

Keren, Ora, Theresa L. Gioannini, Jacob M. Hiller, & Eric J. Simon. (1988). Affinity crosslinking of 125I-labeled human ß-endorphin to cell lines possessing either μ- or δ-type opioid binding sites. Brain Research. 440(2). 280–284. 8 indexed citations

20.

Korczyn, Amos D. & Ora Keren. (1982). The effect of L-dopa on pupillary diameter in mice. Cellular and Molecular Life Sciences. 38(4). 481–482. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact